UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease

European heart journal, 2024-08

2024

Volltextzugriff (PDF)

GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes

JAMA internal medicine, 2024-08

2024

Volltextzugriff (PDF)

Decoy receptors as biomarkers for exploring aetiology and designing new therapies

Clinical kidney journal, 2024-08, Vol.17 (8), p.sfae222

2024

Volltextzugriff (PDF)

Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension

Clinical journal of the American Society of Nephrology, 2024-07

2024

Volltextzugriff (PDF)

Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care

Diabetes research and clinical practice, 2024-07, Vol.213, p.111745, Article 111745

2024

Volltextzugriff (PDF)

SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study

BMJ (Online), 2024-06, Vol.385, p.e078483

2024

Volltextzugriff (PDF)

Biomarkers in clinical epidemiology studies

Clinical kidney journal, 2024-06, Vol.17 (6), p.sfae130

2024

Volltextzugriff (PDF)

Drug stewardship in chronic kidney disease to achieve effective and safe medication use

Nature reviews. Nephrology, 2024-06, Vol.20 (6), p.386-401

2024

Volltextzugriff (PDF)

2576 Effect of dialysis versus conservative care on all-cause mortality in older patients with advanced CKD: nationwide Swedish cohort study

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

762 Hyperkalemia and discontinuation of RAS blockade after initiating SGLT-2i vs. DPP-4i in patients with type 2 diabetes; a population-based cohort study

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

2888 Measured glomerular filtration rate and risk of adverse outcomes in 6059 patients from the Stockholm CREAtinine Measurements (SCREAM) project

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

WCN24-255 Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine Measurements (SCREAM) project

Kidney international reports, 2024-04, Vol.9 (4), p.S544-S545

2024

Volltextzugriff (PDF)

Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care

Nephrology, dialysis, transplantation, 2024-03, Vol.39 (4), p.694-706

2024

Volltextzugriff (PDF)

Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C

Annals of internal medicine, 2024-03, Vol.177 (3), p.269-279

2024

Volltextzugriff (PDF)

A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes

Kidney international, 2024-03, Vol.105 (3), p.618-628

2024

Volltextzugriff (PDF)

Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study

American journal of kidney diseases, 2024-03, Vol.83 (3), p.293-305.e1

2024

Volltextzugriff (PDF)

eGFR slope as a primary endpoint for clinical trials of CKD progression: one size fits all?

Clinical kidney journal, 2024-01, Vol.17 (1), p.sfae001-sfae001

2024

Volltextzugriff (PDF)

Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project

Journal of nephrology, 2024, Vol.37 (4), p.961-972

2024

Volltextzugriff (PDF)

Authors' Reply: Integer Cystatin C Values: Impact on Discordance Group Assignment and Accuracy of GFR-Estimating Equations

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11), p.1915-1916

2023

Volltextzugriff (PDF)

The long-term benefits of early intensive therapy in chronic diseases—the legacy effect

Clinical kidney journal, 2023-11, Vol.16 (11), p.1917-1924

2023

Volltextzugriff (PDF)

Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice

American journal of kidney diseases, 2023-11, Vol.82 (5), p.534-542

2023

Volltextzugriff (PDF)

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

JAMA : the journal of the American Medical Association, 2023-10, Vol.330 (13), p.1266

2023

Volltextzugriff (PDF)

A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality

Kidney international, 2023-09, Vol.104 (3), p.542-551

2023

Volltextzugriff (PDF)

Long-term Visit-to-Visit Variability in Hemoglobin A1c and Kidney-Related Outcomes in Persons With Diabetes

American journal of kidney diseases, 2023-09, Vol.82 (3), p.267-278

2023

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(85)
Buchkapitel
(2)

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(65)
Science & Technology
(65)
Humans
(50)
Medicin Och Hälsovetenskap
(50)
Urology & Nephrology
(38)
Female
(25)
Aged
(24)
Male
(23)
Cohort Studies
(17)
Creatinine
(17)
Glomerular Filtration Rate
(15)
Kidney Diseases
(14)
Middle Aged
(14)
Adult
(12)
Cardiac & Cardiovascular Systems
(12)
Cardiovascular System & Cardiology
(12)
Diabetes
(11)
Diabetes Mellitus, Type 2 - Drug Therapy
(11)
Renal Insufficiency, Chronic - Complications
(11)
Renal Insufficiency, Chronic - Epidemiology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease

GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes

Decoy receptors as biomarkers for exploring aetiology and designing new therapies

Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension

Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care

SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study

Biomarkers in clinical epidemiology studies

Drug stewardship in chronic kidney disease to achieve effective and safe medication use

2576 Effect of dialysis versus conservative care on all-cause mortality in older patients with advanced CKD: nationwide Swedish cohort study

762 Hyperkalemia and discontinuation of RAS blockade after initiating SGLT-2i vs. DPP-4i in patients with type 2 diabetes; a population-based cohort study

1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project

2888 Measured glomerular filtration rate and risk of adverse outcomes in 6059 patients from the Stockholm CREAtinine Measurements (SCREAM) project

WCN24-255 Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine Measurements (SCREAM) project

Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care

Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C

A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes

Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study

eGFR slope as a primary endpoint for clinical trials of CKD progression: one size fits all?

Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project

Authors' Reply: Integer Cystatin C Values: Impact on Discordance Group Assignment and Accuracy of GFR-Estimating Equations

The long-term benefits of early intensive therapy in chronic diseases—the legacy effect

Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality

Long-term Visit-to-Visit Variability in Hemoglobin A1c and Kidney-Related Outcomes in Persons With Diabetes

Suchergebnisse filtern